Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Proteome-wide Profiling of Clinical PARP Inhibitors Reveals Compound-Specific Secondary Targets.

Knezevic CE, Wright G, Remsing Rix LL, Kim W, Kuenzi BM, Luo Y, Watters JM, Koomen JM, Haura EB, Monteiro AN, Radu C, Lawrence HR, Rix U.

Cell Chem Biol. 2016 Dec 22;23(12):1490-1503. doi: 10.1016/j.chembiol.2016.10.011. Epub 2016 Nov 17.

PMID:
27866910
2.

APOSTL: An Interactive Galaxy Pipeline for Reproducible Analysis of Affinity Proteomics Data.

Kuenzi BM, Borne AL, Li J, Haura EB, Eschrich SA, Koomen JM, Rix U, Stewart PA.

J Proteome Res. 2016 Dec 2;15(12):4747-4754. Epub 2016 Oct 21.

PMID:
27680298
3.

Chemoproteomics Reveals Novel Protein and Lipid Kinase Targets of Clinical CDK4/6 Inhibitors in Lung Cancer.

Sumi NJ, Kuenzi BM, Knezevic CE, Remsing Rix LL, Rix U.

ACS Chem Biol. 2015 Dec 18;10(12):2680-6. doi: 10.1021/acschembio.5b00368. Epub 2015 Oct 5.

4.

GSK3 alpha and beta are new functionally relevant targets of tivantinib in lung cancer cells.

Remsing Rix LL, Kuenzi BM, Luo Y, Remily-Wood E, Kinose F, Wright G, Li J, Koomen JM, Haura EB, Lawrence HR, Rix U.

ACS Chem Biol. 2014 Feb 21;9(2):353-8. doi: 10.1021/cb400660a. Epub 2013 Nov 20.

5.

Shared decision making development in Switzerland: room for improvement!

Cornuz J, Kuenzi B, Krones T.

Z Evid Fortbild Qual Gesundhwes. 2011;105(4):296-9. doi: 10.1016/j.zefq.2011.04.008. Epub 2011 Apr 29.

PMID:
21620324
6.

Developing a framework of, and quality indicators for, general practice management in Europe.

Engels Y, Campbell S, Dautzenberg M, van den Hombergh P, Brinkmann H, Szécsényi J, Falcoff H, Seuntjens L, Kuenzi B, Grol R; EPA Working Party.

Fam Pract. 2005 Apr;22(2):215-22. Epub 2005 Feb 18.

PMID:
15722398
7.

Supplemental Content

Loading ...
Support Center